Open Access Article
Celina Bideplán-Moyanoa,
Marcos J. Lo Fiego
b,
Juan José Calmels
a,
Belén Alonsoa,
Gabriel Radivoy
a,
Daniel Ruiz-Molinac,
Juan Mancebo-Aracil
*a and
Fabiana Nador
*a
aInstituto de Química del Sur (INQUISUR-CONICET) – NANOSYN, Departamento de Química, Universidad Nacional del Sur (UNS), Av. Alem 1253, 8000 Bahía Blanca, Buenos Aires, Argentina. E-mail: juan.mancebo@uns.edu.ar; fabiana.nador@uns.edu.ar
bInstituto de Química del Sur (INQUISUR-CONICET) – GIQOS. Departamento de Química, Universidad Nacional del Sur (UNS), Av. Alem 1253, 8000 Bahía Blanca, Buenos Aires, Argentina
cCatalan Institute of Nanoscience and Nanotechnology (ICN2), CSIC and The Barcelona Institute of Science and Technology (BIST), Campus UAB, Bellaterra, 08193 Barcelona, Spain
First published on 13th September 2023
Our study unveils an innovative methodology that merges catechols with mono- and disaccharides, yielding a diverse array of compounds. This strategic fusion achieves robust yields and introduces ligands with a dual nature: encompassing both the chelating attributes of catechols and the recognition capabilities of carbohydrates. This synergistic design led us to couple one of the novel ligands with an Fe(III) salt, resulting in the creation of Coordination Glycopolymer Particles (CGPs). These CGPs demonstrate remarkable qualities, boasting outstanding dispersion in both aqueous media and Phosphate Buffered Saline (PBS) solution (pH ∼7.4) at higher concentrations (0.26 mg μL−1). Displaying an average Z-size of approximately 55 nm and favourable polydispersity indices (<0.25), these particles exhibit exceptional stability, maintaining their integrity over prolonged periods and temperature variations. Notably, they retain their superior dispersion and stability even when subjected to freezing or heating to 40 °C, making them exceptionally viable for driving biological assays. In contrast to established methods for synthesizing grafted glycopolymers, where typically a glycopolymer is doped with catechol derivatives to create synergy between chelating properties and those inherent to the saccharide, our approach provides a more efficient and versatile pathway for generating CGPs. This involves combining catechols and carbohydrates within a single molecule, enabling the fine-tuning of organic structure from a monomer design step and subsequently transferring these properties to the polymer.
Glyconanostructures have emerged as promising tools, leveraging the unique properties of carbohydrates, along with enhanced biocompatibility, bioavailability, and biodegradability.2,5,7 So far, glyconanoparticles,8 glycodendrimers9 and glycoliposomes10 have been reported. Of special relevance are glycopolymers,11 commonly prepared using polymerizable saccharides derivatives or by incorporating saccharides into already formed polymer backbones.12 Several successful examples of glycopolymers and their applications in direct therapeutic methods, medical adhesives, and biosensors have been reported.13,14 However, despite its interest, there are still severe limitations to its successful implementation, among them the nonbiodegradable character of the carbon chain backbones, which have no other biological functions than to serve as spacer units. So, the development of alternative approaches to obtain glycopolymers still represents a challenge nowadays.
Catechol-based derivatives have been shown to be one of the key functionalities in the formation of highly complex macromolecules and organic compounds due to their adhesive properties, metal coordination capabilities, and interaction with nearly any surface.15 They can coordinate with different metal ions, with catechol/Fe(III) complexes being the most extensively studied.16 Different types of materials, including adhesives,17 self-repairing hydrogels,18 dyes,19 coatings,20 and coordination polymers,21 have been developed using the coordination of catechol to Fe(III). In our search to generate catechol-based structures with versatile properties applicable to diverse materials, we have developed a new methodology for synthesising thiol catechol-based derivatives. This involves a conjugate addition reaction of functional mono-, di- and trithiols to freshly prepared o-benzoquinone (Scheme 1).18b,22 Using this technique, a wide variety of products have been successfully synthesised with moderate to good yields.
In this study, we present the organic synthesis of monomers incorporating both catechol and a carbohydrate unit. Our aim is to subsequently generate the glycopolymer through controlled polymerisation in the presence of metal salts, capitalising on the chelating properties of the catechol functionality. To achieve this, we employed a commercial trithiol A following the aforementioned technique, to facilitate the synthesis of derivative 1, which possesses two additional thiols capable of reacting with other substrates (Scheme 2). Compound 1 was then reacted with various peracetylated carbohydrates using a thioglycosylation reaction facilitated by an acidic catalyst.23 This reaction led to the formation of novel catechol–sugar structures after deprotection. We envision that these compounds could be excellent candidates for generating new materials as they leverage the chelating and adhesion properties provided by catechols, as well as the stability, targeting and recognition properties offered by sugars.
![]() | ||
| Scheme 2 Synthesis of catechol–sugar structures 3 by thiol conjugate addition followed by thioglycosylation reaction. | ||
One of the most widely used and efficient ways to generate thioglycosides, especially on a large scale, is by using the corresponding peracetylated monosaccharide dissolved in DCM and a slight excess of a thiol, in the presence of a strong Lewis acid such as BF3·OEt2. By means of this methodology and using simple thiols, the β-acetates reacted faster compared to the α-anomers, resulting in the formation of the corresponding 1,2-trans products due to neighbouring group participation, with yields ranging from good to excellent.23 Following this protocol, Michael adducts 1a and 1b were utilised to carry out the thioglycosylation of peracetylated saccharides such as β-D-glucose pentaacetate (β-D-Glu-OAc), β-D-galactose pentaacetate (β-D-Gal-OAc), α-D-manose pentaacetate (α-D-Man-OAc) and α/β-D-lactose octaacetate (α/β-D-Lac-OAc). To optimise the glycosylation conditions, β-D-Gal-OAc, a slight excess of Michael adduct 1b, and molecular sieves were mixed in DCM under inert atmosphere (Table 1). Then, BF3·OEt2 was added, and the reaction progress was monitored by TLC. The optimisation of reactions conditions mainly focused on varying the β-D-Gal-OAc
:
Michael adduct 1b ratio to determine the optimal proportion for obtaining 2b. In entry 1, a 20% excess of 1b over β-D-Gal-OAc allowed us to exclusively obtain the β-glycosylated product 2b with a yield of 20%. Higher excesses of 1b improved the yield of 2b (entries 2 and 3). This last result may be attributed to the presence of two thiols in the molecule. Therefore, increasing the concentration of 1b would prevent the formation of by-products, such as the addition of two β-D-Gal-OAc units. It is important to note that in all the cases studied, a significant percentage of the excess of 1b could be recovered, reaching nearly 100% recovery when considering the excess of thiol used. Finally, under the same conditions, but using higher amount of the starting substrates, the yield of 2b significantly increased (entries 3 to 5). Furthermore, despite employing nearly twice the amount of reagents as in entry 5, the reaction yield decreased to 41% (entry 6). However, we successfully obtained product 2b on a gram scale, which is highly attractive when considering the potential applications of this compound in functional materials.
| Entry | β-D-Gal-OAc : 1b |
β-D-Gal-OAc (mmol) | 2b yield (%) | 1b recoveryb (%) |
|---|---|---|---|---|
| a Conditions: Gal-OAc, adduct Michael 1b and MS 4 Å were mixed in DCM under N2 atmosphere. Then BF3·OEt2 was added and the reaction monitored by TLC.b Percentage by mass calculated with respect to 1b. | ||||
| 1 | 1 : 1.2 |
0.60 | 20 | 45 |
| 2 | 1 : 1.6 |
0.70 | 24 | 48 |
| 3 | 1 : 2.0 |
0.66 | 37 | 50 |
| 4 | 1 : 2.0 |
0.91 | 41 | 30 |
| 5 | 1 : 2.0 |
1.85 | 50 | 39 |
| 6 | 1 : 2.0 |
3.00 | 41 | 40 |
Under the optimised conditions shown in Table 1, the products depicted in Fig. 1 were obtained. Glycosylation of β-D-Gal-OAc with both Michael adducts 1a and 1b yielded the corresponding β-anomers 2a and 2b after 4 h, with yields of 62% and 50%, respectively. Other peracetylated monosaccharides such as β-D-Glu-OAc and α-D-Man-OAc were also glycosylated, resulting in products 2c and 2d albeit with lower yields. To expand our approximation, the peracetylated disaccharide α/β-D-Lac-OAc was also tested, resulting in the corresponding 2e product with a yield of 19% of β-anomer. In all examples, 1,2-trans glycosides were obtained over the 1,2-cis due to the participatory effect of the neighboring 2-acetyl substituent.24 Furthermore, when α-anomers such as α-D-glucose pentaacetate or α-D-lactose octaacetate were used, no reaction was observed. The addition reaction was also carried out using the thiol saccharide I (Fig. 1) previously synthesised and reported by Lo Fiego et al.25 In this case, product 2f was obtained with a yield of 40%, which is comparable to the yields of the Michael adducts 1.
Moreover, through this reaction, we demonstrated that the methodology was also compatible with silylated groups, which are frequently susceptible to TFA conditions, as well as with more hindered thiols. This result validates that the products can be obtained by forming the Michael adduct with free thiols, and subsequently reacting with the saccharide in a second step through an addition reaction. Alternatively, if the sugar already contains a thiol in its structure, it can directly attack the quinone to form product 2.
To obtain the corresponding deacetylated products, we decided to perform the O-deacetylation of sugars under basic conditions, using either MeONa/MeOH or K2CO3/MeOH. The substrate 2b was dissolved in anhydrous MeOH under an inert atmosphere, followed by the addition of a base such as MeONa or K2CO3. The reaction conditions using K2CO3 as base were found to be the most compatible with the presence of the catechol functionality, which is susceptible to oxidation under basic conditions in presence of mild oxidant like oxygen. Initially, following previously reported saccharides deprotection procedures,26 a deficiency of base with respect to 2b was used, but no reaction progress was observed, leaving the starting substrate intact. Therefore, an excess of base was required for successful deprotection. This could be attributed to the presence of catechols and thiols that can undergo deprotonation in the reaction medium, resulting in an increased consumption of K2CO3. In Table 2 the results of the deprotection of 2b using K2CO3 are presented. In entry 1, the compound 2b was initially dissolved in anhydrous MeOH under an inert atmosphere, and then K2CO3 was added in a 1
:
1.8 ratio (2b
:
K2CO3). After a few minutes, both the desired product 3b and a secondary by-product resulting from the hydrolysis of the ester functionalities present in 2b, were detected (see ESI S1†). To prevent this, the conditions of entry 1 were repeated with a lower amount of K2CO3 which was added in two portions (entry 2). This simple strategy significantly improved the deprotection process, resulting in a 57% yield of product 3b after 1.5 h. Although no hydrolysis by-products were observed, a small amount of substrate 2b remained intact. In entry 3, the conditions of entry 2 were replicated, but the total amount of base was added from the beginning of the reaction. After completion of the reaction, product 3b was purified by washing with diethyl ether, resulting in a 68% yield. At this stage of the optimisation process, we obtained two products: the desired product 3b from the methanolysis of the sugar esters, and undesired by-products involving the methanolysis of the esters present in the starting trithiol backbone (see Fig. S1 in the ESI†). Based on this, we decided to employ two strategies to prevent the undesired methanolysis reactions. Thus, the reaction was carried out by lowering the temperature of the reaction medium to 0 °C (entry 4) or using a less polar solvent (entry 5) to reduce the solubility of K2CO3. However, both reactions were equally disfavoured, and even after 6 h, a significant percentage of the acetylated product 2b remained unreacted, especially under the conditions of entry 5. Based on these observations, the conditions of entry 3 were deemed the most suitable.
| Entry | 2b : K2CO3 |
Solvent | Temp. (°C) | Time (h) | 3b yield (%) |
|---|---|---|---|---|---|
| a Conditions: Substrate 2 (0.22 mmol) was dissolved in anhydrous MeOH (12 mL) under N2 atmosphere and K2CO3 (0.40 mmol) was added. The reaction was monitored by TLC until starting material was consumed. After that, the reaction mixture was passed through a column filled with Dowex 50×, which acted as acid source, and washed with MeOH. The final residue was purified by chromatographic column unless otherwise stated.b 0.20 mmol of K2CO3 were added and the reaction was monitored by TLC. After 0.5 h additional 0.2 mmol K2CO3 were added.c The product was isolated after reverse phase filtration and washed with diethyleter. | |||||
| 1 | 1 : 1.8 |
MeOH | 25 | 2.5 | Traces |
| 2b | 1 : 1.6 |
MeOH | 25 | 1.5 | 57 |
| 3 | 1 : 1.6 |
MeOH | 25 | 1.25 | 68c |
| 4 | 1 : 1.6 |
MeOH | 0 | 6 | <20 |
| 5 | 1 : 1.6 |
DCM : MeOH |
25 | 6 | <20 |
4 : 1 |
|||||
Next, different acids for neutralise the basic reaction medium were tested. When a methanolic solution of HCl (0.34 M) was used, it was observed by 1H NMR that the signals coming from the saccharide started to unfold, possibly due to the formation of new by-products related to ester hydrolysis. We also tested the addition of p-toluensulphonic acid, without obtaining encouraging results. The best conditions found were the use of trifluoroacetic acid or the addition of a Dowex ion exchange resin. Fig. 2 shows the products obtained after O-deacetilation of products 2, with yields ranging from moderate to very good.
Following a methodology previously reported,22a compound 2b was selectively dimerised using I2 to form the disulphide 4a (Scheme 4) with quantitative yield. These novel structures, incorporating both catechols and sugars, offer chelating and coordination properties with metal ions. Additionally, the presence of carbohydrates could provide stabilisation in biological environments, as well as recognition and targeting capabilities. Based on these considerations, the ligand 4a in combination with Fe(III) were appropriated candidates for the preparation of novel CGPs (Fig. 3a). The process began by dissolving ligand 4a in a mixture of DMSO and MeOH, followed by the gradual addition of an aqueous solution of FeCl3·6H2O under magnetically stirring. This resulted in the formation of a green-blue suspension with a slight precipitation of a solid material. Subsequently, a 0.1 M aqueous solution of NaOH was added until a deep violet-blue colour was achieved. The solution was then stirred for 3 h, followed by centrifugation, washing with water and MeOH, and finally freeze-dried. Regarding the ligand 4a
:
Fe ratios, we decided to conduct several tests by varying the proportions and determining the mass of the precipitated solid. The best condition was found to be a 1
:
1 ratio, resulting in a solid yield between of 60–75%. The solid was then analysed by UV-Vis, IR, SEM, EDX, DLS and atomic absorption techniques.
Firstly, to determine the type of interaction between Fe(III) and 4a, we analysed both the obtained suspension and the precipitated using UV-Vis. According to the literature,27 iron solutions containing catechol moieties adjusted to a pH value of 6–7 result in a 2
:
1 catechol
:
iron bis species, which exhibits a UV-Vis maximum at 570 nm, corresponding to a deep blue colour. Alternatively, at pH values above 9.5, tris species (3
:
1, catechol
:
iron) are formed, with a UV-Vis maximum at 490 nm corresponding to a red colour. Based on these data, we conducted the synthesis under three different conditions (Fig. 3b and c), as follows. (A) Mixing only ligand 4a in DMSO/MeOH and adding an aqueous iron solution resulted in a green-blue coloured solution displaying an absorption band at 630 nm. However, no solid formation was observed. (B) Mixing 4a, dissolved in DMSO/MeOH, with an aqueous iron solution and adding 0.1 M NaOH until the solution change to violet-blue. This solution exhibited an absorption band at 547 nm, and a significant amount of violet-blue precipitate, displaying an absorption band at 568 nm (see Fig. 3d). These results indicated that both the solid and the suspension predominantly consisted of bis-catecholate species. (C) Mixing 4a, dissolved in DMSO/MeOH, with an aqueous iron solution and adding 0.1 M NaOH until a red-purple coloured solution appeared with an absorption band at 440 nm. Additionally, a significant amount of violet-blue precipitate formed, corresponding to an absorption band at 568 nm. These last results suggested that the species present in the suspension were different from those found in the precipitate. In summary, the addition of NaOH solution was necessary to promote the formation of the solid CGPs, we assumed that this base would be assisting in the deprotonation of the catechol and consequently in the coordination with iron.27,28 Moreover, the analysis of conditions (B) and (C) showed that regardless of the change in pH, once the violet-blue solid was formed, further increases in the amount of base did not change its colouration and consequently its structure. We obtained CGPs corresponding to the interaction of two catecholates per Fe ion, indicating a ligand
:
Fe ratio of 1
:
1, considering the ligand's bidentate nature (Fig. 3a). These data correlate perfectly with the observations made during the initial optimisation, where an excess of ligand 4a relative to Fe at ratios of 2
:
1 or even 3
:
1 did not result in an increased amount of precipitated solid. Furthermore, the analysis by atomic absorption of the product dissolved in concentrated acid mixture yielded a percentage of Fe consistent with the expected ligand–metal ratio (see Experimental section).
To exclude the possibility that the observed precipitate may originate from the oxidation and precipitation of ligand 4a, it was subjected to the same optimised reaction conditions, but in the absence of the metal. It was observed that the solution remained colourless for 20 minutes, but thereafter it started to change its colour, acquiring a yellow/brownish appearance, which is typical of polymers and oligomers generated by the oxidation of the catechol molecules. However, even after 24 h of reaction, no precipitation was observed. This solution was also analysed using UV-Vis spectroscopy to confirm the absence of any absorption band above 400 nm (Fig. S3†).
The characterisation of CGPs was also performed using IR spectroscopy with KBr pellets, confirming the presence of the main bands of ligand 4a in the solid (Fig. S4†). Even when a decrease in the intensity of the O–H stretching band (3550–3320 cm−1) of the free catechols present in the starting ligand 4a was observed compared to the CGPs, their complete disappearance was not detected. This could be attributed to partial deacetylation of the acetyl groups present in the sugar, which can readily hydrolyse in the light basic media. Additionally, a band centred in 620 cm−1 was observed, which could be assigned to the Fe–O interaction resulting from the coordination of the catecholate with Fe.
The CGPs sample was also characterised using SEM microscopy, which revealed a homogeneous composition consisting primarily of oval-shaped nanoparticles arranged in chains and clusters. The average diameter ranged between 400 ± 150 nm (Fig. S6†). Additionally, EDX spectrum confirmed the presence of S, C, O and Fe elements throughout the entire analysed surface (Fig. S7†).
The freeze-dried solid was then studied using DLS to evaluate the average particle size in solution and assess the dispersion and stability of the system in different media. The first assay we conducted was an attempt to redisperse the CGPs solid in different organic solvents. DMSO, which is a commonly used solvent in biological assays, resulted in the most efficient due to this solution quickly acquired a violet-blue colour without any suspended solids or precipitates (see Fig. S8†). Additionally, we attempted to disperse the solid directly in water or a PBS buffer (pH ∼ 7.4), but the process was not successful, resulting in a significant amount of precipitated solid. Based on these preliminary results and with the intention of using our CGPs in future bioassays, we decided to prepare solutions of different concentrations of CGPs in DMSO and gradually add them to water or PBS buffer (see Fig. S9a†). Our goal with these assays was to prepare CGPs/DMSO solutions with the highest possible concentration, enabling the addition of a significant amount of CGPs to aqueous media while minimising the required volume of DMSO. Typically, the limit of DMSO for biological assays is around 4% or less in H2O or physiological media. With this in mind, the best results obtained were those corresponding to concentrations of 0.25 mg μL−1 of CGPs in H2O. These solutions revealed a Z average mean size around 35–65 nm and low PdI values (<0.25) (Fig. S9b†). The same analysis was carried out with PBS solutions (pH ∼ 7.4) with good quality measurements but with a larger Z average distribution around 55–105 nm (see Fig. S10†). The more concentrated samples were also analysed over time in aqueous media, revealing a slight increase in Z average mean size and very good stability even after 7 days without the presence of sedimented sample (see Fig. S11†). Due to the excellent stability results obtained for the CGPs in an aqueous medium, at this point, we decided to take it one step further and exposed the samples to two temperature conditions. One of them was frozen at −37 °C, and the other was heated to 40 °C for 1 hour. Both samples showed the same quality measurements by DLS as at room temperature, revealing the suitability of these samples to proceed to a phase of biological testing (Fig. 3f and g).
In conclusion, our research has accomplished the development of novel glycopolymer compounds with exceptional stability in water, indicating their potential applications in various fields. Additionally, our advances in organic synthesis have allowed the production of pure products through efficient and few-step synthetic routes. We believe that this work establishes a solid foundation for future investigations in the field of glycopolymer research and their applications in diverse scientific and technological domains.
NMR spectra were recorded on a Bruker ARX-300 spectrometer using CDCl3 or CD3OD as solvents. High-resolution mass spectra were recorded using a Bruker micrOTOF-Q II mass spectrometer under ESI ionisation mode. IR spectra were recorded on a Nicolet Nexus FT spectrophotometer instrument in the range of 4000–400 cm−1 using KBr pellets. UV-Vis spectra of liquid samples were obtained on a Cary 60 UV-Vis Spectrophotometer from Agilent, equipped with a Xenon flash lamp (80 Hz), double beam photometric system and 1.5 nm spectral bandwidth. Spectra were collected on a range wavelength from 200 to 800 nm. UV-Vis spectra of CGPs were registered on a Thermo Scientific™ ISA-220 with Integrating Sphere Accessory in reflectance configuration. Spectra were collected on a range wavelength from 300 to 1100 nm.
CGPs samples were lyophilised with a Rificor L-A-B4 freeze dry acrylic chamber. Temperature range −40 °C to 40 °C. Vacuum power: 0.001 mm Hg. SEM images were performed in a LEO EVO 40XVP system operated at 10 kV coupled to an EDX detector Oxford X-Max 50. Samples were prepared by drop casting of the corresponding dispersion on an aluminium tape followed by evaporation of the solvent under room conditions, then metallised with gold in a sputter coater.
The CGPs iron content was determined by using an Atomic Absorption Spectrometer, AAnalyst200 from PerkinElmer equipped with a Fe hollow cathode lamp (HCLs). Before its use, all glass material was washed with HNO3 and rinsed with distilled water. The standard solution from Merck Certipur of 1000 ppm Fe in 5% HNO3 was diluted up to prepare the calibration curves (1, 3 and 6 ppm). Size distribution and electrophoretic mobilities were measured using a Malvern Zetasizer Nano ZS90 equipment.
:
AcOEt, 70
:
30). 1H NMR (300 MHz, CDCl3) δ 7.00 (dd, J = 7.8, 1.6 Hz, 1H), 6.92 (dd, J = 8.1, 1.6 Hz, 1H), 6.79 (deform. dd, J = 8.1, 7.8 Hz, 1H), 6.56 (br. s, 1H, OH), 5.40 (br. s, 1H, OH), 2.70 (t, J = 7.3 Hz, 2H), 2.51 (deform. dt, J = 7.8, 7.3 Hz, 2H), 1.63–1.51 (m, 4H), 1.40–1.36 (m, 4H), 1.33 (t, J = 7.8 Hz, 1H, SH). 13C NMR (75 MHz, CDCl3) δ 143.9 (C); 143.6 (C); 126.2 (CH); 120.5 (CH); 119.4 (C); 116.1 (CH); 36.1 (CH2); 33.5 (CH2); 29.2 (CH2); 27.7 (CH2); 27.5 (CH2); 24.2 (CH2).
:
AcOEt, 60
:
40). 1H NMR (300 MHz, CDCl3) 7.00–6.92 (m, 3H, OH), 6.79 (deform. dd, J = 7.8 Hz, 1H), 5.96 (s, 1H, OH), 4.09 (s, 6H), 2.97 (t, J = 6.6 Hz, 2H), 2.82–2.72 (m, 4H), 2.70–2.65 (m, 4H), 2.56 (t, J = 6.6 Hz, 2H), 1.64 (t, J = 8.2 Hz, 2H, SH), 1.51 (q, J = 7.5 Hz, 2H), 0.91 (t, J = 7.6 Hz, 3H). 13C NMR (75.5 MHz, CDCl3) δ 172.0 (CO), 171.7 (2× CO); 145.1 (C); 144.6 (C); 127.0 (CH); 121.2 (CH); 118.0 (C); 117.0 (CH); 64.3 (CH2); 64.0 (2× CH2); 40.9 (C); 38.6 (2× CH2); 34.0 (CH2); 31.4 (CH2); 23.1 (CH2); 19.9 (2× CH2), 7.6 (CH3).
:
AcOEt, 60
:
40). 1H NMR (300 MHz, CDCl3) δ 6.96 (dd, J = 7.7, 1.5 Hz, 1H), 6.87 (dd, J = 8.1, 1.5 Hz, 1H), 6.75 (deform. dd, J = 8.1, 7.7 Hz, 1H), 6.58 (br. s, 1H, OH), 5.74 (br. s, 1H, OH), 5.41 (d, J = 3.1 Hz, 1H), 5.21 (deform. dd, J = 10.0, 9.9 Hz, 1H), 5.03 (dd, J = 9.9, 3.1 Hz, 1H), 4.44 (d, J = 10.0 Hz, 1H), 4.15 (dd, J = 11.3, 6.7 Hz, 1H), 4.08 (dd, J = 11.3, 6.6 Hz, 1H), 3.90 (deform. dd, J = 6.7, 6.6 Hz, 1H), 2.71–2.60 (m, 4H), 2.12, 2.04, 2.02, 1.97 (s, 12H, 4× CH3CO), 1.66–1.47 (m, 4H), 1.46–1.26 (m, 4H). 13C NMR (75.5 MHz, CDCl3) δ 170.4, 170.2, 170.1, 169.6 (4× CO); 144.2 (C); 143.8 (C); 126.3 (CH); 120.6 (CH); 119.2 (C); 116.2 (CH); 84.0 (CH); 74.3 (CH); 71.8 (CH); 67.2 (CH); 67.2 (CH); 61.4 (CH2); 36.3 (CH2); 29.9 (CH2); 29.3 (CH2), 29.3 (CH2); 28.0 (CH2); 27.9 (CH2); 20.7 (CH3), 20.6 (2× CH3), 20.5 (CH3). HRMS (ESI) m/z calcd for C26H36NaO11S2+, [M + Na]+: 611.1597; found 611.,1591.
:
AcOEt, 50
:
50). 1H NMR (300 MHz, CDCl3) 6.99 (dd, J = 7.8, 1.4 Hz, 1H), 6.94 (dd, J = 7.9, 1.4 Hz, 1H), 6.79 (deform. dd, J = 7.9, 7.8 Hz, 1H), 5.43 (dd, J = 3.3, 1.1 Hz, 1H), 5.23 (deform. dd, J = 10.1, 9.9 Hz, 1H), 5.05 (dd, J = 10.1, 3.3 Hz, 1H), 4.51 (d, J = 9.9 Hz, 1H), 4.18–4.03 (m, 8H), 3.94 (td, J = 6.6, 1.1 Hz, 1H), 3.04–2.85 (m, 4H), 2.81–2.66 (m, 6H), 2.53 (t, J = 6.6 Hz, 2H), 2.16, 2.07, 2.05, 1.99 (4s, 12H, 4× CH3CO), 1.65 (t, J = 8.1 Hz, 1H, SH), 1.50 (q, J = 7.5 Hz, 2H), 0.90 (t, J = 7.5 Hz, 3H), OH n.d. 13C NMR (75.5 MHz, CDCl3) δ 171.6, 171.5, 171.4, 170.4, 170.2, 170.0, 169.6 (7× CO); 145.0 (C); 144.5 (C); 126.8 (CH); 121.0 (CH); 117.9 (C); 116.9 (CH); 84.4 (CH); 74.5 (CH); 71.9 (CH); 67.3 (CH); 67.1 (CH); 64.2 (CH2); 64.0 (CH2); 63.9 (CH2); 61.5 (CH2); 40.8 (C); 38.4 (CH2); 35.3 (CH2), 33.8 (CH2); 31.3 (CH2); 25.3 (CH2); 23.0 (CH2); 20.9 (CH3); 20.7 (2× CH3); 20.7 (CH3); 19.7 (CH2); 7.4 (CH3). HRMS (ESI) m/z calcd for C35H48NaO17S3+, [M + Na]+: 859.1951; found 859.1946.
:
AcOEt, 50
:
50). 1H NMR (300 MHz, CDCl3) 6.98 (dd, J = 7.8, 1.6 Hz, 1H), 6.92 (dd, J = 7.9, 1.6 Hz, 1H), 6.78 (deform. dd, J = 7.9, 7.8 Hz, 1H), 5.21 (deform. dd, J = 9.8, 9.7 Hz, 1H), 5.12–4.98 (m, 2H), 4.51 (d, J = 10.0 Hz, 1H), 4.23 (dd, J = 12.4, 4.8 Hz, 1H), 4.10–4.04 (m, 7H), 3.70 (ddd, J = 10.1, 4.9, 2.5 Hz, 1H), 2.97 (t, J = 6.5 Hz, 2H), 2.96 (t, J = 7.0 Hz, 1H), 2.88 (t, J = 6.9 Hz, 1H), 2.80–2.63 (m, 6H), 2.54 (t, J = 6.5 Hz, 2H), 2.07, 2.04, 2.02, 2.00 (4s, 12H, 4× CH3CO), 1.63 (t, J = 8.2 Hz, 1H, SH), 1.49 (q, J = 7.5 Hz, 2H), 0.89 (t, J = 7.5 Hz, 3H), OH n.d. 13C NMR (75.5 MHz, CDCl3) δ 171.7, 171.4, 171.4, 170.6, 170.1, 169.4, 169.4 (7× CO); 144.9 (C); 144.4 (C); 126.7 (CH); 120.9 (CH); 117.8 (C); 116.8 (CH); 83.9 (CH); 76.1 (CH); 73.9 (CH); 69.8 (CH); 68.4 (CH); 64.2 (CH2); 64.0 (CH2); 63.9 (CH2); 62.2 (CH2); 40.8 (C); 38.3 (CH2); 35.2 (CH2), 33.7 (CH2); 31.3 (CH2); 25.1 (CH2); 22.9 (CH2); 20.7 (2× CH3); 20.6 (2× CH3); 19.6 (CH2); 7.5 (CH3). HRMS (ESI) m/z calcd for C35H48NaO17S3+, [M + Na]+: 859.1951; found 859.1946.
:
AcOEt, 50
:
50). 1H NMR (300 MHz, CDCl3) 6.93 (br. s, 1H, OH), 6.91 (d, J = 7.8 Hz, 1H), 6.85 (dd, J = 8.0 Hz, 1H), 6.72 (deform. dd, J = 7.9, 7.8 Hz, 1H), 5.78 (br. s, 1H, OH), 5.30–5.22 (m, 2H), 5.16 (dd, J = 10.1, 3.2 Hz, 1H), 4.33–4.15 (m, 2H), 4.10–3.97 (m, 8H), 2.90 (t, J = 6.6 Hz, 2H), 2.82 (deform. dd, J = 6.8, 6.6 Hz, 1H), 2.75–2.56 (m, 7H), 2.48 (t, J = 6.6 Hz, 2H), 2.10, 2.04, 1.98, 1.92 (4s, 12H, 4× CH3CO), 1.57 (t, J = 8.2 Hz, 1H, SH), 1.43 (q, J = 7.4 Hz, 2H), 0.84 (t, J = 7.4 Hz, 3H). 13C NMR (75.5 MHz, CDCl3) δ 171.8, 171.6, 171.3, 170.8, 170.1, 170.0, 169.9 (7× CO); 145.0 (C); 144.5 (C); 126.9 (CH); 121.1 (CH); 117.9 (C); 116.9 (CH); 85.8 (CH); 71.0 (CH); 69.5 (CH); 69.3 (CH); 66.3 (CH); 64.1 (CH2); 64.0 (CH2); 63.9 (CH2); 62.5 (CH2); 40.9 (C); 38.5 (CH2); 34.6 (CH2); 33.9 (CH2); 31.5 (CH2); 26.4 (CH2); 23.0 (CH2); 21.0 (CH3); 20.9 (CH3); 20.8 (2× CH3); 19.8 (CH2); 7.5 (CH3). HRMS (ESI) m/z calcd for C35H48NaO17S3+, [M + Na]+: 859.1951; found 859.1949.
:
AcOEt, 50
:
50). 1H NMR (300 MHz, CDCl3) 7.11 (d, J = 7.7, 1H), 6.94 (d, J = 8.0 Hz, 1H), 6.77 (deform. dd, J = 8.0, 7.7 Hz, 1H), 6.56 (br. s, 1H, OH), 5.36–5.21 (m, 2H), 5.19–5.08 (m, 2H), 4.97–4.89 (m, 2H), 4.53–4.39 (m, 2H), 4.18–3.98 (m, 10H), 3.92–3.73 (m, 2H), 3.07 (t, J = 7.1 Hz, 2H), 2.79–2.71 (m, 4H), 2.66–2.62 (m, 4H), 2.58 (t, J = 7.1 Hz, 2H), 2.14, 2.11, 2.10, 2.07, 2.05, 2.04, 1.96 (7s, 21H, 7× CH3CO), 1.61 (t, J = 8.1 Hz, 1H, SH), 1.48 (q, J = 7.3 Hz, 2H), 0.89 (t, J = 7.3 Hz, 3H). 13C NMR (75.5 MHz, CDCl3) δ 171.5, 171.4, 170.5, 170.4, 170.2× 3, 169.7, 169.3, 169.2 (10× CO); 144.7 (C); 144.3 (C); 129.1 (CH); 120.9 (CH); 120.2 (C); 118.4 (CH); 101.2 (CH); 101.0 (CH); 76.2 (CH); 73.1 (CH); 72.4 (CH); 71.6 (CH); 71.0 (CH); 70.9 (CH); 69.2 (CH); 68.2 (CH); 66.7 (CH); 64.1 (CH2); 64.0 (CH2); 61.9 (CH2); 60.9 (CH2); 60.8 (CH2); 40.8 (C); 38.5× 2 (CH2); 38.4 (CH2); 34.4 (CH2), 28.9 (CH2); 23.1 (CH2); 21.1 (CH3); 21.0 (2× CH3); 20.9 (2× CH2); 20.8 (CH3); 20.6 (CH3); 19.8 (CH2); 7.5 (CH3).
:
AcOEt, 30
:
70). 1H NMR (300 MHz, CDCl3) δ 7.28 (s, 1H, OH), 7.01 (dd, J = 7.8, 1.6 Hz, 1H), 6.93 (J = 8.0, 1.6 Hz, 1H), 6.76 (deform. dd, J = 8.0, 7.8 Hz, 1H), 5.45 (s, 1H, OH), 4.74 (d, J = 1.2 Hz, 1H), 4.00 (d, J = 1.3 Hz, 1H), 3.93–3.88 (m, 2H), 3.39 (s, 3H), 3.28–3.08 (qd, J = 7.1 Hz, 1.3 Hz, 1H), 1.28 (d, J = 7.1 Hz, 3H), 0.90 (s, 9H, (CH3)3CSiMe2), 0.83 (s, 9H, (CH3)3CSiMe2), 0.10, 0.09, 0.07, 0.03 (4s, 12H, 4× CH3, (CH3)2SiBut). 13C NMR (75 MHz, CDCl3) δ 145.4 (C); 144.3 (C); 128.0 (CH); 120.5 (CH); 117.6 (C); 116.5 (CH); 109.4 (CH); 85.5 (CH); 84.1 (CH); 80.7 (CH); 55.0 (CH3O); 46.3 (CH); 25.8 ((CH3)3CSiMe2); 25.7 ((CH3)3CSiMe2); 17.9 (C, Me3CSiMe2); 17.8 (C, Me3CSiMe2); 15.5 (CH3); −4.1, −4.5, −4.6, −4.9 (4× Me, (CH3)2SiBut). HRMS (ESI) m/z calcd for C25H46NaO6SSi2+, [M + Na]+: 553.2451; found 553.2446.
:
MeOH, 80
:
20). 1H NMR (300 MHz, CD3OD) δ 6.84 (dd, J = 7.5, 1.8 Hz, 1H), 6.74 (dd, J = 8.0, 1.8 Hz, 1H), 6.67 (deform. dd, J = 8.0, 7.5 Hz, 1H), 4.32 (d, J = 9.3 Hz, 1H), 3.91 (d, J = 3.2 Hz, 1H), 3.77 (dd, J = 11.4, 6.9 Hz, 1H), 3.71 (dd, J = 11.4, 5.4 Hz, 1H), 3.57 (deform. dd, J = 9.3, 9.2 Hz, 1H), 3.56–3.52 (m, 1H), 3.46 (dd, J = 9.2, 3.2 Hz, 1H), 2.80 (t, J = 7.2 Hz, 2H), 2.78–2.64 (m, 2H), 1.68–1.55 (m, 4H), 1.50–1.36 (m, 4H), OH n.d. 13C NMR (75 MHz, CD3OD) δ 146.3 (C); 146.2 (C); 124.7 (CH); 122.4 (C); 120.7 (CH); 115.7 (CH); 87.6 (CH); 80.4 (CH); 76.2 (CH); 71.4 (CH); 70.4 (CH); 62.5 (CH2); 34.7 (CH2); 30.8 (CH2); 30.7 (CH2); 30.3 (CH2); 29.3 (CH2); 29.2 (CH2).
:
MeOH, 70
:
30). 1H NMR (300 MHz, CD3OD) 6.84 (d, J = 7.7 Hz, 1H), 6.76 (dd, J = 7.8 Hz, 1H), 6.66 (deform. dd, J = 7.8, 7.7 Hz, 1H), 4.35 (d, J = 9.2 Hz, 1H), 4.09–4.04 (m, 6H), 3.88 (d, J = 3.1 Hz, 1H), 3.78–3.64 (m, 2H), 3.58–3.44 (m, 3H), 3.06 (t, J = 6.9 Hz, 2H), 3.00–2.85 (m, 2H), 2.78–2.71 (m, 4H), 2.69–2.64 (m, 2H), 2.59 (t, J = 6.8 Hz, 2H), 1.52 (q, J = 7.6 Hz, 2H), 0.92 (t, J = 7.4 Hz, 3H), OH n.d. 13C NMR (75.5 MHz, CD3OD) δ 173.4, 173.2, 173.1 (3× CO); 146.8 (C); 146.5 (C); 125.7 (CH); 120.8 (C); 120.8 (CH); 116.4 (CH); 87.8 (CH); 80.6 (CH); 76.2 (CH); 71.3 (CH); 70.5 (CH); 65.1 (CH2); 65.0 (CH2); 65.0 (CH2); 62.6 (CH2); 42.1 (C); 39.5 (CH2); 36.5 (CH2); 35.3 (CH2); 29.9 (CH2); 26.3 (CH2); 24.0 (CH2); 20.3 (CH2); 7.7 (CH3).
:
AcOEt, 30
:
70). 1H NMR (300 MHz, CDCl3) δ 7.02 (s, 2H, OH), 6.97 (d, J = 7.9 Hz, 2H), 6.93 (d, J = 8.0 Hz, 2H), 6.78 (deform. dd, J = 8.0, 7.9 Hz, 2H), 5.99 (s, 2H, OH), 5.42 (d, J = 3.3 Hz, 2H), 5.22 (deform. dd, J = 10.0, 9.9 Hz, 2H), 5.04 (dd, J = 10.0, 3.3 Hz, 2H), 4.51 (d, J = 9.9 Hz, 2H), 4.15–4.01 (m, 16H), 3.93 (t, J = 6.5 Hz, 2H), 3.02–2.84 (m, 12H), 2.78–2.68 (m, 8H), 2.54 (t, J = 6.5 Hz, 4H), 2.14, 2.06, 2.03, 1.98 (4s, 24H, 8× CH3CO), 1.49 (q, J = 7.4 Hz, 4H), 0.89 (t, J = 7.4 Hz, 6H). 13C NMR (75 MHz, CDCl3) δ 171.7, 171.5, 171.4, 170.4, 170.2, 170.0, 169.6 (14× CO); 144.9 (2× C); 144.4 (2× C); 126.7 (2× CH); 120.9 (2CH); 117.8 (2× C); 116.8 (2× CH); 84.3 (2× CH); 74.4 (2× CH); 71.7 (2× CH); 67.1 (2× CH); 67.0 (2× CH); 64.1 (2× CH2); 63.9 (2× CH2); 63.8 (2× CH2); 61.3 (2× CH2); 40.7 (2× C); 35.2 (2× CH2); 33.9 (2× CH2); 33.7 (2× CH2); 32.7 (2× CH2); 31.3 (2× CH2); 25.2 (2× CH2); 22.8 (2× CH2); 20.8 (2× CH3); 20.7 (2× CH3); 20.7 (2× CH3); 20.6 (2× CH3); 7.3 (2× CH3). HRMS (ESI) m/z calcd for C70H94NaO34S6+, [M + Na]+: 1693.3848; found 1693.3843.Footnote |
| † Electronic supplementary information (ESI) available: NMR, UV-Vis, IR and EDX spectra, DLS measurements and SEM images. See DOI: https://doi.org/10.1039/d3ra05316d |
| This journal is © The Royal Society of Chemistry 2023 |